GlassScriptPhysician profile
Brereton Strafford
NPI 1407834641
$2,124.70
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $294 · 2021: $338 · 2022: $449 · 2023: $277 · 2024: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $478.75 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $442.77 | 2019-2024 | Euflexxa |
| Smith+Nephew, INC. | $352.29 | 2019-2023 | Evos, Trigen Intertan |
| Pacira Therapeutics, INC. | $223.48 | 2019-2021 | |
| Heron Therapeutics, INC. | $90.73 | 2021-2024 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $68.12 | 2019-2020 | |
| Stryker Corporation | $67.73 | 2022-2023 | Iconix |
| Avanos Medical | $57.18 | 2019 | |
| Fidia Pharma USA INC. | $54.06 | 2019-2024 | Hyalgan, Hymovis, Triluron |
| Zimvie INC. | $51.98 | 2022 | |
| Orthofix Medical, INC. | $38.53 | 2022-2023 | Physio-Stim |
| Abbott Laboratories | $33.53 | 2024 | Proclaim |
| Horizon Therapeutics Plc | $27.64 | 2019 | |
| Linvatec Corporation | $21.95 | 2024 | Biobrace 23mm |
| Innovation Technologies INC | $21.64 | 2024 | Irrisept |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $15.86 | 2023 | Monovisc, Orthovisc |
| Kowa Pharmaceuticals America, INC. | $14.43 | 2022 | |
| Merck Sharp & Dohme LLC | $13.64 | 2021 | |
| Lima USA, INC. | $13.25 | 2020 | |
| Si-Bone, INC. | $12.89 | 2023 | |
| Arteriocyte Medical Systems, INC. | $12.57 | 2019 | |
| Endo Pharmaceuticals INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brereton Strafford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.